SURVIVAL AND TOXICITY UPDATE OF THE PHASE 2 TRIAL OF BEVACIZUMAB (BV) IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS
Published
Conference Paper
Full Text
Duke Authors
Cited Authors
- Desjardins, A; Reardon, DA; Peters, KB; Herndon, JE; Kirkpatrick, JP; Friedman, HS; Vredenburgh, JJ
Published Date
- November 1, 2010
Published In
Volume / Issue
- 12 /
Start / End Page
- 77 - 77
Published By
Pages
- 1
International Standard Serial Number (ISSN)
- 1522-8517
Conference Name
- Advances in Inflammatory Bowel Diseases Crohns and Colitis Foundations National Clinical and Research Conference
Conference Location
- Hollywood, FL
Conference Start Date
- December 9, 2010
Conference End Date
- December 12, 2010